News

Gladstone in the News August 28, 2024

Structure Search Suggests Roles for Thousands of Viral Proteins

Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.

Gladstone Experts Infectious Disease Doudna Lab

Article August 28, 2024

Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy

A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.

News Release Research (Publication) COVID-19 Neurological Disease Infectious Disease Akassoglou Lab

Gladstone in the News August 27, 2024

San Francisco’s Role in the Mpox Fight

The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.

Gladstone Experts Infectious Disease Ott Lab

Article August 26, 2024

3D Shapes of Viral Proteins Point to Previously Unknown Roles

Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies

News Release Research (Publication) Data Science and Biotechnology Infectious Disease Doudna Lab CRISPR/Gene Editing

Gladstone in the News July 19, 2024

With COVID Summer Wave Underway, When Should You Get Your Next Vaccine Shot?

San Francisco Chronicle—With the United States now experiencing a typical summer COVID surge, Gladstone Senior Investigator Nadia Roan helps break down how to make a personal decision about when to get your next vaccine.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Gladstone in the News March 4, 2024

The Blood Holds Clues to Understanding Long COVID

Science News—In some people with long COVID, powerful immune players called T cells seem to go out of whack. In some long COVID patients, T cells that recognize SARS-CoV-2 can become exhausted, Nadia Roan's team reported in Nature Immunology in January. And scientists know that tired-out T cells can have trouble wiping out infection.

Research (Publication) COVID-19 Infectious Disease Roan Lab

Gladstone in the News January 12, 2024

‘Striking’ Study Reveals Immune System Anomalies in People with Long COVID

San Francisco Chronicle—At least 10 percent of those who survive COVID continue to face debilitating symptoms months after the acute infection resolves. New research from the laboratory of Gladstone Senior Investigator Nadia Roan shows that individuals suffering Long Covid have a dysregulated immune response to the virus and evidence of T cell exhaustion, which may be due to the virus persisting within their bodies.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Article January 11, 2024

In Patients with Long COVID, Immune Cells Don’t Follow the Rules

Scientists at Gladstone Institutes and UC San Francisco analyzed immune cells in people with and without long COVID, making significant discoveries that will help answer questions about what causes the condition and how to treat it

News Release Research (Publication) COVID-19 Infectious Disease Roan Lab

Article December 11, 2023

Reflections on a Pandemic: 6 Questions with Melanie Ott

Melanie Ott, director of the Gladstone Institute of Virology, reflects on the breakthroughs driven by the COVID-19 pandemic and explains why virologists’ work is never done

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News November 23, 2023

Inside Long COVID’s War on the Body: Researchers Are Trying to Find Out Whether the Virus Has the Potential to Cause Cancer

Fortune—Researchers are investigating the possibility that people who suffer from Long COVID might be at elevated risk of developing cancer. Melanie Ott, director of the Gladstone Institute of Virology, explains that viruses related to SARS-CoV-2 have been shown to inactivate oncosuppressor proteins, which may predispose patients to cancer.

Gladstone Experts Cancer COVID-19 Infectious Disease Ott Lab

Article July 10, 2023

How Understanding RNA Structure Can Help Researchers Design Better HIV Drugs

New research sheds light on the biological effect of the many possible three-dimensional structures of a critical loop of RNA in HIV

Research (Publication) HIV/AIDS Infectious Disease Ott Lab

Gladstone in the News May 26, 2023

Fall’s COVID Shots May Be Different in One Key Way

The Atlantic—The next generation of COVID vaccines may be directed against just one lineage of the Omicron strain. Melanie Ott, director of the Gladstone Institute of Virology, explains why that could be a smart strategy to elicit a strong immune response.

Gladstone Experts COVID-19 Infectious Disease Ott Lab

Gladstone in the News May 3, 2023

Should I Bother Getting a Bivalent COVID Booster Now?

San Francisco Chronicle—Gladstone Senior Investigator Nadia Roan explains that while prior vaccination or exposure to COVID-19 may confer long-term protection against serious disease, a booster shot with the bivalent vaccine will protect you for a few months against new infection.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Video April 20, 2023

40 Years of HIV Research: Celebrating the Career of Virologist Warner Greene

Colleagues look back on Warner Greene's 40 year career

Gladstone Experts History HIV/AIDS Infectious Disease Greene Lab

Article December 16, 2022

Tips from Virologists to Face the “Tripledemic” This Holiday Season

Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab Roan Lab